Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > APRE Aprea Therapeutics > Detailed Quotes

APRE Aprea Therapeutics

0.702
+0.035+5.25%
Close 10/05 16:00 ET
High
0.733
Open
0.670
Turnover
36.37K
Low
0.660
Pre Close
0.667
Volume
52.92K
Market Cap
16.44M
P/E(TTM)
Loss
52wk High
5.670
Shares
23.40M
P/E(Static)
Loss
52wk Low
0.620
Float Cap
13.22M
Bid/Ask %
50.00%
Historical High
53.110
Shs Float
18.82M
Volume Ratio
0.79
Historical Low
0.620
Dividend TTM
--
Div Yield TTM
--
P/B
-0.46
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.28%
Amplitude
10.94%
Avg Price
0.687
Lot Size
1
Float Cap
13.22M
Bid/Ask %
50.00%
Historical High
53.110
Shs Float
18.82M
Volume Ratio
0.79
Historical Low
0.620
Dividend TTM
--
P/B
-0.46
Dividend LFY
--
Turnover Ratio
0.28%
Amplitude
10.94%
Avg Price
0.687
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Aprea Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the provision of cancer therapeutics. It is involved in the development and commercialization of novel cancer therapeutics that reactivate mutant p53 tumor suppressor protein. The company was founded by Vladimir Bykov, Klas Gota Wiman, Staffan Stromblad, Natalia Issaeva, Galina Selivanova, and Wen Jie Bao in 2002 and is headquartered in Boston, MA.
CEO: Dr. Oren Gilad, PhD
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...